Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment

INTRODUCTION: Glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) approved to date are administered by injection; therefore, patient perceptions of an oral GLP-1 RA are unknown. This discrete choice experiment explored preferences for (unbranded) oral and injectable GLP-1 RA profiles among Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Igarashi, Ataru, Bekker Hansen, Brian, Langer, Jakob, Tavella, Francesca, Collings, Hannah, Davies, Neil, Wyn, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854394/
https://www.ncbi.nlm.nih.gov/pubmed/33245530
http://dx.doi.org/10.1007/s12325-020-01561-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854394/
https://www.ncbi.nlm.nih.gov/pubmed/33245530
http://dx.doi.org/10.1007/s12325-020-01561-1

Ejemplares similares